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Measles: effect of a two-dose vaccination
programme in Catalonia, Spain
P. Godoy,1 A. Domı´nguez,2 & L. Salleras3
The study reports incidences of measles in Catalonia, Spain, as detected by surveillance, and analyses the specific
characteristics of the outbreaks reported for the period 1986–95. Incidences per 100 000 inhabitants were
calculated for the period 1971–95. The following variables were studied: year of presentation, number of cases,
median age, transmission setting, cases with a record of vaccination and preventable cases. Associations between
variables were determined using odds ratios (OR). The incidence of measles declined from 306.3 cases in 1971 to
30.9 in 1995. A total of 50 outbreaks were investigated. The outbreaks that occurred in the last two years of the
study had a higher likelihood of having a transmission setting other than primary school (OR = 3.9); a median case
age > 10 years (OR = 7.2); and fewer than 6 cases (OR = 2.3). The characteristics of recent outbreaks, marked by a
rise both in transmission outside the primary-school setting and in median age, indicate the need for the introduction
of a specific vaccination programme at the end of adolescence in addition to control of school-related outbreaks.
Voir page 136 le re´sume´ en franc¸ais. En la pa´gina 136 figura un resumen en espan˜ol.
Introduction
Throughout history, measles has occasioned high
mortality and morbidity. Nowadays, despite being a
preventable disease, it still gives rise to 45 million
cases and over one million deaths worldwide each
year (1, 2).
The availability of an attenuated vaccine of
proven high efficacy (90–95%), the markedly stable
nature of the virus, the nonexistence of carriers, and
the fact that humans constitute the sole disease
reservoir (3, 4), led to the proposal that measles
could be eliminated from extensive geographical
areas. Hence, within the context of the strategy of
‘‘Health for all by the year 2000’’, the European
Region of WHO proposed that measles should be
eliminated from all countries in the region by the
year 2000.
Subsequently, however, epidemiological data
have indicated that in developed countries, even
with vaccine coverage approaching 100%, sporadic
cases and epidemic outbreaks of measles could
continue to appear (5, 6), owing to the difficulty of
achieving sufficient herd immunity to eliminate a
disease whose level of airborne communicability is
far higher than had been supposed. In 1991 the
European Region of WHO therefore set a new
target: that by the year 2000 the incidence of
measles in all Member States in the region would be
less than 1 per 100 000 inhabitants. More recently it
has been recommended that the date for elimina-
tion should be set between 2005 and 2010 (7).
Diverse strategies have been proposed to control
the disease and its subsequent eradication (3, 4, 8).
It is absolutely essential, however, that region-
specific measles epidemiology should be ascer-
tained so that the methods best adapted to the
respective characteristics of each location can be
applied (9, 10).
In Catalonia (population 6 million), an autono-
mous region situated in north-east Spain, a
systematic immunization programme was intro-
duced in 1981, based on the administration of a
single dose of measles vaccine at the age of 12
months. Since 1988, two doses of vaccines have
been administered: the first at 15 months, and the
second at 11 years. On the basis of the number of
doses of vaccine distributed to vaccination centres,
it is estimated that vaccination coverage for cohorts
born after 1981 is in excess of 95%. In 1991 a health
plan was drawn up which aimed among other things
at eliminating indigenous measles by the year 2000
and reducing the disease incidence to less than 10
per 100 000 by 1995. Nevertheless, and bearing in
mind that surveillance was incomplete, the lowest
incidence for the entire period (10.6 per 100 000
inhabitants) occurred in 1993, with no epidemic
outbreak of measles being detected. In 1994 and
especially in 1995 there was a rise in the incidence
and the number of reported outbreaks.
The present study sought to assess the
measles elimination strategy in Catalonia by examin-
ing incidence trends over the last 25 years and
analysing the specific characteristics of the outbreaks
registered in the period 1986–95.
1 Department of Health and Social Security, Generalitat of Catalonia;
and Faculty of Medicine, University of Lleida. Requests for reprints
should be sent to this author at the following address: C/Vall d’Aneu
45, 25199 Lleida, Spain.
2 Department of Health and Social Security, Directorate of Public
Health, Generalitat of Catalonia; and Faculty of Medicine, University of
Barcelona, Barcelona, Spain.
3 Faculty of Medicine, University of Barcelona, Barcelona, Spain.
132 # World Health Organization 1999 Bulletin of the World Health Organization, 1999, 77 (2)
Research
Materials and methods
Historically, records of notifiable diseases in Spain
have been based on the number of cases reported by
local public health authorities. In January 1982, a
directive came into force in Catalonia which
reformed the disease notification procedure. Under
the terms of this directive, in addition to local public
health authorities, the heads of health care centres
(in- and outpatient) were also required to return a
form showing the number of diseases diagnosed by
all physicians in their centres. Among the diseases to
be reported by this procedure was measles, which,
along with the others, was to be reported on a
clinically suspect case basis, as determined by the
physician’s criteria.
It was subsequently recommended that the
following clinical case definition of measles be used
for reporting purposes: a disease displaying the
following characteristics: a) generalized maculopap-
ular rash; b) fever >38.3 oC; and c) cough, rhinitis or
conjunctivitis. Preventable cases were deemed to be
those that had not been vaccinated in accordance
with the vaccination schedule, in the absence of any
medical contraindications or objections to vaccin-
ation of a religious and/or philosophical nature.
The measles time–trend study was based on
year-by-year aggregation of weekly reports received
by the Department of Public Health and Social
Security for the period January 1971 to December
1995. For rate calculation purposes, the 1971, 1981
and 1991 official census population plus the
intercensus population calculated by the National
Statistic Office (Instituto Nacional de Estadistica) were
used. The trend in the incidence over time was
studied using Pearson’s correlation coefficient r.
There is a statutory duty in Catalonia to report
epidemic outbreaks to the Provincial Public Health
and Social Security Authorities. Once investigation
and adoption of the relevant lines of action have
been completed, the technical staff must then draw
up a health status report and forward it to the
Department of Public Health and Social Security. To
study such outbreaks, we reviewed all reports on
measles outbreaks that had been sent to the General
Directorate of Public Health since 1986 (the year
when for the first time since 1982 measles outbreaks
were reported and studied in Catalonia). A measles
outbreak was defined as the association of two or
more cases within a maximum period of 18 days.
The variables studied were as follows: year of
presentation (divided into three periods: 1986–87,
1988–93 and 1994–95); reporting delay in days;
existence of serologically confirmed cases; number
of cases; median age; transmission setting; number
of cases with a record of vaccination; and number of
preventable cases. Association of the dependent
variable (year of presentation) with the remaining
variable of the study was determined using the odds
ratio (OR), with a 95% confidence interval (CI).
Data were analysed using the Epi Info 6.04 software
package.
Results
The incidence of measles per 100 000 inhabitants, as
registered by the epidemiological surveillance system,
Table 1. Number of notified cases of measles and investigated outbreaks of measles in Catalonia,
1986–95
No. of notified Rate per No. of cases No. of
Year cases of measles 100 000 in outbreaks outbreaks
inhabitants
1986 5 489 92.2 21 (0.4)a 1 (2.0)
1987 2 612 43.6 21 (0.8) 2 (4.0)
1988 1 869 31.7 3 (0.2) 1 (2.0)
1989 7 022 117.4 42 (0.6) 1 (2.0)
1990 1 242 20.7 171 (13.8) 3 (6.0)
1991 1 821 30.4 62 (3.4) 4 (8.0)
1992 3 596 59.3 182 (5.1) 10 (20.0)
1993 645 10.6 0 (0.0) 0 (0.0)
1994 453 7.5 43 (9.5) 5 (10.0)
1995 1 838 30.9 137 (7.4) 23 (46.0)
Total 26 587 682 (2.6) 50 (100.0)
a Figures in parentheses are percentages.
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declined from 306.30 cases in 1971 to 30.9 in 1995
(Fig. 1). The incidence fell over this period by 89.9%,
yielding a statistically significant (P = 0.001) Pearson
correlation coefficient r = –0.67. From 1971 to 1981
there were important outbreaks every two years.
Subsequently, despite an increase in the number of
reporting centres, a marked decrease in incidence was
observed in association with the establishment of the
vaccination programme (Fig. 1). It should be noted
that, following the sharp decline in 1983, incidences
nevertheless increased in subsequent years, i.e. 1985
(144.3 per 100 000), 1989 (117.4), 1992 (59.3), and
1995 (30.9).
In all, 50 outbreaks, with a total of 682 cases,
were investigated. The number of outbreaks per year
varied from none at all in 1993 to 23 in 1995. The
proportion of cases of measles involved in outbreaks
with respect to the number of numerically notified
cases varied from 0% (in 1993) to 13.8% (in 1990)
(Table 1). Outbreaks were notified to the epidemi-
ological surveillance system with a median reporting
delay of 15 days (range: 1–72); and the median
number of cases per outbreak was 6 (range: 2–95).
In 20% of outbreaks (10/50) there were
serologically confirmed cases. Statistically significant
differences in median age of cases, primary-school
transmission, number of cases and proportion of
vaccinated cases were not observed between
laboratory-confirmed outbreaks and those with only
epidemiological confirmation (Table 2).
The most frequent transmission settings were
as follows: primary school (50%), family (18%),
community (12%), secondary school (8%), nursery
school (4%), armed forces (3%), and hospital (2%).
One or more cases were hospitalized in 11 outbreaks
(22.0%) and overall, 4.1% of all cases were admitted
to hospital. An important proportion of cases
(44.9% (245/545)) had been vaccinated (Table 3),
0.9% (5/545) with two doses and 44.0% (240/545)
with a single dose; only 27.8% (148/532) were
preventable.
The median age of measles cases in 45.8% of
outbreaks was 6–10 years, and in 18.7%, 16–20
years. The median age for the remaining outbreaks
was distributed in a lower proportion among the
other age groups. A shift to the older groups was
observed with time. For the 0–5-year group, 83.3%
of the outbreaks occurred in 1988–93, while for
people aged515 years all the outbreaks occurred in
1994–95 (Table 4).
The outbreaks in the last two years of the
study (1994 and 1995) had a higher likelihood of
having the following: a transmission setting other
than primary school (OR = 3.9, 95% CI = 1.0–16.4);
a median age above 10 years (OR = 7.2, 95%
CI = 1.4–41.2); and fewer than 6 cases per outbreak
(OR = 2.3, 95% CI = 0.6–9.3) (Table 5).
Discussion
Following introduction of the vaccination pro-
gramme, measles incidences in Catalonia declined
markedly (89.9%), akin to that witnessed by other
countries (4, 11). However, after an initial drop in the
incidence (5, 11, 12), important epidemics took place
in 1985, 1989, 1992 and 1995, although in no instance
reaching the levels registered prior to the introduc-
tion of the vaccination programme.
Table 2. Specific characteristics of outbreaks of measles with and
without serological confirmation in Catalonia, 1986–95
Serological confirmation: Odds
Variable Yes No ratio
Median age (years)
0–10 4 (40.0)a 14 (40.0) Reference
>10 6 (60.0) 24 (60.0) 0.9; 0.2–4.5b
Primary-school transmission
Yes 4 (40.0) 21 (52.5) Reference
No 6 (60.0) 19 (47.5) 1.7; 0.3–8.5
No. of cases
>6 6 (60.0) 19 (47.5) Reference
2–6 4 (40.0) 21 (52.5) 0.6; 0.1–3.0
% vaccinated
0–30 6 (60.0) 10 (26.3) Reference
31–60 1 (10.0) 16 (42.1) 0.1; 0.0–1.1
61–100 4 (30.0) 12 (31.6) 0.4; 0.1–2.7
a Figures in parentheses are percentages.
b Figures in italics are 95% confidence intervals.
Table 3. Distribution of cases with record of vaccination and
preventable cases in reported outbreaks in Catalonia, 1986–95
Variable No. of casesa
Vaccinated
Yes 245 (44.9)b
1 dose 240 (44.0)
2 doses 5 (0.9)
No 300 (55.1)
Preventable
Yes 148 (27.8)
No 384 (72.1)
a Excluding cases without data for the variable shown.
b Figures in parentheses are percentages.
Table 4: Distribution of outbreaks of measles in Catalonia,
by median age of cases, 1986–95
Period
Median agea 1986–1987 1988–1993 1944–1995
(years) n n n Total
0–5 0 (0.0)b 5 (83.3) 1 (16.7) 6
6–10 3 (13.6) 9 (40.9) 10 (45.4) 22
11–15 0 (0.0) 3 (50.0) 3 (50.0) 6
16–20 0 (0.0) 0 (0.0) 9 (100.0) 9
>20 0 (0.0) 0 (0.0) 5 (100.0) 5
Total 3 17 28 48
a Data were not reported in two outbreaks.
b Figures in parentheses are percentages.
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An increase in cases, especially in the form of
outbreaks, often affecting a high proportion of the
vaccinated population, has been observed in a
number of countries after such initial periods of
apparent control (3, 4, 11–13). Among the reasons
that can be adduced to explain such outbreaks, the
following warrant special mention (3, 14, 15): a) the
highly contagious nature of measles, surpassing that
estimated in the mathematical models used; b)
primary (14, 16) and secondary (16, 17) vaccine
failures; c) defects in vaccination programmes, with
different proportions of children without access to
vaccines (11); and d) other aspects, such as the role
of already immune persons or asymptomatic cases in
transmission — among the vaccinated population in
particular — could also play an important part in the
evolution of epidemic outbreaks (5, 14).
The study’s main limitation is the lack of
information on the validity of measles reporting in
Catalonia. Only the outbreaks that were reported
and investigated were analysed. Outbreaks are
under-registered compared with the numerically
reported cases. Moreover, only 20% of outbreaks
were serologically confirmed. Although the clinical
profile of measles has traditionally been considered
very characteristic, a number of studies have shown
that the positive predictive value of measles
reporting may be very low, particularly in countries
in which incidence declines and there is an
appreciable proportion of cases with a record of
having been vaccinated (9, 10, 18). In any outbreak,
a reporting delay, in addition to adversely affecting
the validity of the data, limits the efficacy of any
control measures adopted (19, 20). It has been
stressed that availability of quick, straightforward
analytical techniques, such as salivary diagnosis,
would facilitate both epidemiological surveillance of
the disease and swift introduction of control
measures (4, 21–24).
The median age of cases in 45.8% of
outbreaks was 6–10 years, and in 18.7%, 16–20
years, suggesting that, as indicated in other studies
(4, 21), the age of cases tends to be much older than
those reported prior to vaccination; a shift of the
outbreaks to the older age groups is observed. In
Catalonia, the 5–10-year age group will have
contained some cohorts that were vaccinated at
age 12 months, which probably entailed a higher
proportion of primary vaccine failures (6, 16). The
16–20-year age group will have comprised cohorts
with lower vaccine coverage and a lower opportu-
nity to develop natural immunization because of
lower circulation of the virus. It has already been
observed that this age segment is a risk group for
measles (6, 25).
In agreement with other studies (11, 25), the
most frequent transmission settings proved to be
primary schools and households. In recent years, a
lower yet highly significant proportion of cases has
been registered in secondary schools (age
515 years) and in the armed forces. Health care
centres have been repeatedly described as a risk
setting for measles transmission, and this should be
borne in mind in outbreak control (26, 27).
An important proportion of cases (44.9%) had
been vaccinated. This is comparable to that found in
other studies and congruent with an acceptable
vaccine coverage (28, 29). In countries that increase
measles vaccination coverage, the proportion of
cases with a record of vaccination also increases. Only
five cases had a previous history of two doses of
vaccine and these represent the infrequent primary
vaccine failures that do not seroconvert (30).
Measles epidemiology underscores the sound-
ness of the 1988 decision to incorporate a second
dose of vaccine, though this too should perhaps be
boosted by some complementary measure. Among
the cases with a record of vaccination, 97.8% had
received a single dose of vaccine; in addition, 45.8%
of the outbreaks occurred in the 5–10-year age
group. These findings indicate that administration of
the second dose of measles–mumps–rubella (MMR)
combined vaccine at age 4–6 years (before starting
school) instead of at 11 years of age could prevent an
important proportion of outbreaks in Catalonia.
Also, the recent increase of transmission among
adolescents and young adults indicates that existing
strategies should be supplemented by control of
immunization status at the end of adolescence (3, 4,
23, 31, 32), on termination of secondary school, or
on entrance to university, the labour market or the
military (31).
Other countries have administered this second
dose of vaccine using the catch-up strategy (3, 4, 7,
17, 23), inoculating all persons aged 1–14 years,
irrespective of their vaccine or disease case histories,
thereby achieving temporary elimination of measles
virus. Certain aspects of this strategy still remain to
be elucidated, however, such as how campaigns
should be scheduled and which age groups should
be covered (13).
Table 5. Specific characteristics of outbreaks of measles in
Catalonia, 1986–95
Period
Variable 1986–87 1988–93 1994-95
Median age (years)
0–10 3 (100.0)a 14 (82.3) 11 (39.3)
>10 0 (0.0) 3 (17.6) 17 (60.7)
Odds ratio 0; 0.0–19.6b Reference 7.2; 1.4–41.2
Primary-school transmission
Yes 2 (66.7) 13 (68.4) 10 (35.7)
No 1 (33.7) 6 (31.6) 18 (64.3)
Odds ratio 0; 0.0–19.6 Reference 3.9; 1.0–16.4
No. of cases
>6 2 (66.7) 10 (52.6) 9 (32.1)
2–6 1 (33.7) 9 (47.4) 19 (67.8)
Odds ratio 0.6; 0.1–10.4 Reference 2.3; 0.6–9.3
a Figures in parentheses are percentages.
b Figures in italics are 95% confidence intervals.
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In order to achieve elimination of measles
before the year 2000, the dual strategies of catch-up
vaccination of some cohorts of students (probably
aged 7–18 years) and bringing forward the second
dose to age 4–6 years should be considered. Both
strategies will reduce the number of susceptible
individuals in those age groups that appear to be
more susceptible for measles transmission. In view
of the organizational requirements and economic
burden of such a strategy, it is probably only feasible
if it is coordinated with other European countries
and with the specific aim of eliminating the disease
in the region (33).
As for all diseases in the process of being
eliminated, it is essential to establish an epidemi-
ological surveillance system that allows confirmation
of each reported case, characterization of the virus
involved using molecular epidemiology and detailed
study of each outbreak (7, 25, 28, 33). Such
information is essential in order to reorientate the
strategies of vaccination programmes and to certify
the eventual elimination of disease in a particular
area (7, 25, 33). n
Re´sume´
Rougeole : effet d’un sche´ma de vaccination a` deux doses en Catalogne (Espagne)
La Catalogne (Espagne) s’est donne´ pour but d’e´liminer
la rougeole autochtone d’ici l’an 2000; toutefois,
malgre´ une couverture vaccinale acceptable, le nombre
de flambe´es s’est accru ces derniers temps. L’article
donne les chiffres d’incidence fournis par le syste`me de
surveillance et analyse les caracte´ristiques propres des
flambe´es signale´es au cours de la pe´riode 1986-1995.
Les auteurs ont calcule´ l’incidence de la rougeole
pour 100 000 habitants au cours de la pe´riode 1971-
1995. Ils ont de´fini une flambe´e de rougeole comme
l’association de deux cas ou davantage et e´tudie´ les
variables suivantes : anne´e de pre´sentation, nombre de
cas, aˆge me´dian des cas, lieu de transmission, cas ayant
des ante´ce´dents de vaccination et cas e´vitables. Pour
de´terminer l’association de la variable de´pendante avec
les autres tableaux de l’e´tude, on a utilise´ l’odds ratio
(OR) et un intervalle de confiance (IC) de 95%.
L’incidence pour 100 000 habitants mesure´e par
le syste`me de surveillance est tombe´e de 306,3 cas en
1971 a` 30,9 cas en 1995. Au total, 50 flambe´es
totalisant 682 cas ont e´te´ e´tudie´es. Le nombre me´dian
de cas par flambe´e e´tait de 6 (valeurs limites : 2-95).
L’aˆge moyen des cas e´tait de 6-10 ans dans 45,8% des
flambe´es et de 16-20 ans dans 18,7% des autres. Les
lieux de transmission les plus fre´quents e´taient les
suivants : e´coles primaires (50%) et me´nages (18%).
Dans une proportion importante (44,9%) les cas
avaient e´te´ vaccine´s et seuls 27,8% d’entre eux se
sont re´ve´le´s eˆtre e´vitables. Les flambe´es des deux
dernie`res anne´es de l’e´tude (1994 et 1995) avaient une
plus grande probabilite´ de correspondre a` des situations
du type suivant : lieu de transmission autre qu’une
e´cole primaire (OR=3,9; IC a` 95%=1,0-16,4); aˆge
me´dian des cas >10 ans (OR=7,2; IC a` 95 % =1,4-
41,2); effectif infe´rieur a` 6 cas (OR=2,3; IC a` 95 %=
0,6-9,3).
Les caracte´ristiques des re´centes flambe´es de
rougeole survenues en Catalogne, marque´es par une
augmentation de lieux de transmission autres que les
e´coles primaires et de l’aˆge me´dian des cas, soulignent
la ne´cessite´ de mettre en place un programme
spe´cifique de vaccination a` la fin de l’adolescence, en
plus de la lutte contre les foyers de rougeole en milieu
scolaire. L’introduction d’un syste`me de controˆle des
dossiers individuels de vaccination a` la fin des e´tudes
secondaires ou encore a` l’entre´e a` l’universite´ ou lors du
service militaire, pourrait contribuer a` faire reculer le
nombre de ces flambe´es.
Resumen
Sarampio´n: efecto de una pauta de vacunacio´n con dos dosis en Catalun˜a (Espan˜a)
Se ha fijado la meta de eliminar el sarampio´n indı´gena
en Catalun˜a (Espan˜a) para el an˜o 2000; sin embargo,
pese a haberse alcanzado una cobertura aceptable de
vacunacio´n, recientemente se ha detectado un
aumento del nu´mero de brotes. En el presente estudio
se da cuenta de las incidencias detectadas por el
sistema de vigilancia y se analizan las caracterı´sticas
especı´ficas de los brotes notificados durante el periodo
1986-1995.
Se calcularon las cifras de incidencia de
sarampio´n por 100 000 habitantes correspondientes
al periodo 1971-1995. Se califico´ de brote toda
asociacio´n de dos o ma´s casos, y se estudiaron las
siguientes variables: an˜o de presentacio´n, nu´mero de
casos, edad mediana de los casos, entorno de
transmisio´n, casos con registro de vacunacio´n y casos
prevenibles. La asociacio´n entre la variable dependiente
(an˜o de presentacio´n) y los datos de las restantes tablas
del estudio se determino´ mediante la razo´n de
posibilidades («odds ratio», OR), con un intervalo de
confianza (IC) del 95%.
La incidencia de sarampio´n por 100 000
habitantes detectada por el sistema de vigilancia
disminuyo´ de 306,3 casos en 1971 a 30,9 en 1995.
Se investigaron en total 50 brotes, que sumaron 682
casos. La mediana de casos por brote fue de 6
(intervalo: 2-95). La edad mediana de los casos fue de
6-10 an˜os en el 45,8% de los brotes, y de 16-20 an˜os
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en el 18,7%. Los entornos de transmisio´n ma´s
frecuentes fueron la escuela primaria (50%) y el hogar
(18%). Una importante proporcio´n de los afectados
(44,9%) habı´a sido vacunado, y so´lo un 27,8% de los
casos era prevenible. En los brotes declarados en los
dos u´ltimos an˜os del estudio (1994 y 1995) concurrı´a
con mayor probabilidad alguna de las siguientes
circunstancias: un entorno de transmisio´n distinto de
la escuela primaria (OR = 3,9, IC 95% = 1,0-16,4); una
edad mediana de los casos >10 an˜os (OR = 7,2, IC
95% = 1,4-41,2); y menos de 6 casos (OR = 2,3, IC
95% = 0,6-9,3).
Las peculiaridades de los brotes observados
recientemente en Catalun˜a, caracterizados por un
aumento de la transmisio´n en entornos distintos de la
escuela primaria y por un incremento de la edad
mediana, indican que es necesario aplicar un programa
de vacunacio´n especı´fico al te´rmino de la adolescencia
como elemento adicional de la lucha contra los brotes
escolares. La implantacio´n de sistemas de control
destinados a vigilar la situacio´n inmunitaria de los
jo´venes al acabar la escuela secundaria o al iniciar los
estudios universitarios o el servicio militar podrı´a
contribuir al control de esos brotes.
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